The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, targets a different hormone called amylin, lost as much as 20% weight.

Obesity is the excessive or abnormal accumulation of fat or adipose tissue in the body that impairs health via its ...

A recent review explored the evolution of visual arts in cardiovascular medicine over time, the understanding, diagnosis, and ...

Arrowhead Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to investigational plozasiran as an adjunct to ...

Weight gain often appears straightforward — consuming more calories than the body burns leads to extra pounds. However, ...

In today’s fast-paced digital world, trends spread like wildfire, often sparking intense debate and concern, particularly ...

A powerful earthquake that struck Calama in 2024 defied long-held assumptions about how deep earthquakes behave. In July 2024 ...

Globally, metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease, affecting up to one in three people in the general population, with an ...